ISSN 2073–4034
eISSN 2414–9128

Place Of Ciclosporin A In Modern Therapy Of Rheumatoid Arthritis

E.L. Luchihina

Place of ciclosporin A in modern therapy of rheumatoid arthritis
The article dedicated to problem of treatment of rheumatoid arthritis (RA). At the present time, cyclosporine A (CyA) – immunosuppressant with selective effect on the T-lymphocytes especially without cytotoxic effects of immunosuppression - is effective medicine of pathogenetic therapy of RA in patients poor under the standard basic therapy or in cases ineffectiveness of treatment by methotrexate. CyA regimen in RA is well established and provides a treatment monitoring. In case of insufficient response to treatment, combined therapy including using a combination of CyA with genetically engineered biological reparations is feasible.

Keywords

rheumatoid arthritis
methotrexate
genetically engineered biological preparations
cyclosporin A

Similar Articles

By continuing to use our site, you consent to the processing of cookies that ensure the proper functioning of the site.